ArticleApplied microbiology and biotechnology2026
Intracellular β-glucosidase regulates cellulase expression and development in Aspergillus nidulans.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
β-Glucosidases (EC 3.2.1.21) are essential enzymes involved in biomass degradation and metabolic regulation, but the physiological roles of intracellular β-glucosidases in filamentous fungi remain incompletely understood. In this study, we characterized CbgA (AN10124) and CbgB (AN10375), two intracellular glycoside hydrolase family 1 β-glucosidases, in Aspergillus nidulans. Gene deletion and biochemical analyses demonstrated that CbgA is the predominant intracellular β-glucosidase. Loss of cbgA led to overactivation of cellulases, cellobiose-dependent accumulation of reddish-brown secondary metabolites, and a significant reduction in conidiation. Crucially, deletion of the cellobiose transporter gene cltB in the ΔcbgA background markedly attenuated these phenotypes, providing direct genetic evidence that the ΔcbgA-associated defects are driven by intracellular cellobiose accumulation rather than energy deficiency. Our findings identify CbgA as a critical "signal gatekeeper" that modulates the intensity of cellobiose-dependent induction. By maintaining the intracellular cellobiose pool within a physiological range, CbgA prevents secretory overload and maintains the metabolic balance between primary development and secondary metabolism. This study clarifies the coordination between nutrient transport and intracellular metabolism in shaping global regulatory outputs, suggesting that the targeted modulation of CbgA activity represents a potential strategy for optimizing cellulase production in fungal cell factories. KEY POINTS: CbgA negatively regulates cellulase expression by controlling intracellular cellobiose levels. Loss of cbgA leads to hyperpigmentation and reduced conidiation on cellobiose. Deletion of cltB alleviates ΔcbgA phenotypes, confirming the role of intracellular cellobiose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.